Testosterone has been previously shown to induce persistent susceptibility to Plasmodium chabaudi malaria in otherwise resistant female C57BL/6 mice. Here, we investigate as to whether this conversion coincides with permanent changes of hepatic gene expression profiles. Female mice aged 10-12 weeks were treated with testosterone for 3 weeks; then, testosterone treatment was discontinued for 12 weeks before challenging with 10 6 P. chabaudi-infected erythrocytes. Hepatic gene expression was examined after 12 weeks of testosterone withdrawal and after subsequent infection with P. chabaudi at peak parasitemia, using Affymetrix microarrays with 22 690 probe sets representing 14 000 genes. The expression of 54 genes was found to be permanently changed by testosterone, which remained changed during malaria infection. Most genes were involved in liver metabolism: the female-prevalent genes Cyp2b9, Cyp2b13, Cyp3a41, Cyp3a44, Fmo3, Sult2a2, Sult3a1, and BC014805 were repressed, while the male-prevalent genes Cyp2d9, Cyp7b1, Cyp4a10, Ugt2b1, Ugt2b38, Hsd3b5, and Slco1a1 were upregulated. Genes encoding different nuclear receptors were not persistently changed. Moreover, testosterone induced persistent upregulation of genes involved in hepatocellular carcinoma such as Lama3 and Nox4, whereas genes involved in immune response such as Ifng and Igk-C were significantly decreased. Our data provide evidence that testosterone is able to induce specific and robust long-term changes of gene expression profiles in the female mouse liver. In particular, those changes, which presumably indicate masculinized liver metabolism and impaired immune response, may be critical for the testosterone-induced persistent susceptibility of mice to P. chabaudi malaria.
Introduction
Testosterone is known to increase susceptibility to a wide variety of infectious diseases (Mü ller 1992, Klein 2000 , Roberts et al. 2001 , Marriott & Huet-Hudson 2006 , which also concerns human malaria (Mü ller 1992, Kurtis et al. 2001 , Muehlenbein et al. 2005 . In the experimental mouse malaria Plasmodium chabaudi, testosterone has been shown to induce a lethal outcome of otherwise self-healing infections (Wunderlich et al. 1988 (Wunderlich et al. , 1991 . Remarkably, this testosterone-induced conversion from resistance to susceptibility becomes somehow imprinted in female mice, i.e. it persists for rather a long time. Thus, when mice are pretreated with testosterone for 3 weeks, and then testosterone treatment is discontinued for 12 weeks, thereafter the mice are still susceptible to P. chabaudi infections (Benten et al. 1997) . Obviously, this testosterone-induced susceptibility persists, even though the circulating testosterone levels have declined to those levels characteristic for female mice after withdrawal for 12 weeks (Benten et al. 1997) . This indicates that testosterone is able to induce changes in mice, which continue to exist at low testosterone levels.
The liver is known to be a target organ for testosterone to mediate intrahepatic immune responses (Häussinger et al. 2004 ) and to play a central role in malaria. Indeed, the liver is not only that site in which the pre-erythrocytic development of malaria parasites takes place, but also it is an important effector against malarial blood stages (Balmer et al. 2000 , Krü cken et al. 2005 , though largely neglected by current research. Moreover, specific populations of lymphocytes have been described to be generated in the liver, which mediate novel protective immune mechanisms against malaria blood stages in the mouse (Mannoor et al. 2001 (Mannoor et al. , 2002 . Also, Kupffer cells are able to eliminate, via phagocytosis, parasite-derived material such as hemozoin and even Plasmodium-infected erythrocytes (Aikawa et al. 1980) . Moreover, the liver is known for its sexual dimorphism, in particular for its sex-and testosteronedependent pattern of phase I and phase II metabolism (Waxman & Holloway 2009 ). All this information led us to suppose that the liver may be one of those sites which is critically involved in mediating the suppressive testosterone effects on P. chabaudi malaria.
Testosterone acts on gene expression either directly through the androgen receptor (AR; Zhou et al. 1994 , Quigley et al. 1995 , Bennett et al. 2009 or indirectly by crosstalk with other signaling pathways , Rahman & Christian 2007 , Wendler & Wehling 2009 ). Moreover, testosterone has been described to induce changes in gene expression, including those genes involved in liver metabolism (Kato & Onada 1970 , Krü cken et al. 2005 , Waxman & Holloway 2009 ). However, there is no information available that testosterone is able to induce permanent changes in gene expression of the liver, i.e. changes that persist even after withdrawal of testosterone. This view prompted us to investigate possible permanent testosterone effects on hepatic gene expression using the Affymetrix microarray technology. At least, the present study provides evidence that testosterone is able to induce permanent changes in the expression of distinct genes in the liver, which, when once induced by treatment with testosterone for 3 weeks, remain existing even for at least 12 weeks after discontinuation of the testosterone treatment. In addition, the expression of such genes is rather robust upon infecting with P. chabaudi malaria, which is discussed with respect to relevance for the testosterone-induced persistent susceptibility of mice to P. chabaudi malaria.
Materials and methods
Mice C57BL/6 mice were bred under specific pathogen-free conditions at the central animal facilities of our university. Experiments were performed with female mice. They were housed in plastic cages, and they received a standard diet (Wohrlin, Bad Salzuflen, Germany) and water ad libitum. The experiments were approved by the state authorities and followed German law on animal protection.
Testosterone treatment
Mice aged 10-12 weeks received s.c. injections of 100 ml sesame oil containing 0 . 9 mg testosterone (Testosterone-Depot-50, Schering, Berlin, Germany) twice a week for 3 weeks (Wunderlich et al. 1988 , Benten et al. 1997 .
Controls were treated only with vehicle, i.e. sesame oil. Thereafter, they were kept under standard conditions for 12 weeks.
Infections
Blood stages of P. chabaudi were passaged weekly in NMRI mice (Wunderlich et al. 1982 , Krü cken et al. 2009 ). C57BL/6 mice were challenged with 10 6 P. chabaudi-parasitized erythrocytes. Parasitemia was determined in Giemsa-stained tail blood, and cell number was measured in a Neubauer chamber.
RNA isolation
Three mice per time point were killed by cervical dislocation, and livers were aseptically removed. Liver pieces were rapidly frozen in melting nitrogen and stored at K80 8C. For isolation of RNA, w250 mg frozen liver were homogenized with an ultra turrax in 5 ml Trizol (Peqlab Biotechnology, Erlangen, Germany) for 1 min, mixed with 1 ml chloroform for 15 s, incubated for 15 min at room temperature, and centrifugated at 3000 g for 45 min. The supernatant was treated with isopropanol and centrifugated, and the pellet was washed twice with 80% ethanol, air-dried, and dissolved in 200 ml RNase-free water. RNA concentrations were determined at 260 nm, and the quality of the RNA was examined with agarose gel electrophoresis.
Hybridization of microarrays
Quality control of RNA was performed with a Bioanalyzer 2100 (Agilent Technologies, Waldbronn, Germany) on an RNA 6000 Nano chip. RNA was quantified using the RiboGreen RNA Quantitation kit (Molecular Probes, Leiden, The Netherlands). Biotinlabeled cRNA was synthesized from 5 mg total RNA using the One cycle kit (Affymetrix, Inc., Santa Clara, CA, USA) according to the manufacturer's protocol. Biotinlabeled cRNA (15 mg) was then hybridized to Affymetrix MOE430A Gene Chips for 16 h at 45 8C. The chips were stained and washed on an Affymetrix Fluidics Station 400, and the fluorescence of the hybridized cRNA was read with an Affymetrix 300 Scanner. The chips were quality controlled with the software 'Expressionist Refiner' (GeneData AG, Basel, Switzerland) detecting and correcting gradients, spots, and distortions. Each probe set is represented by 11 pairs of 25 mer perfect match and mismatch oligonucleotides. Using the MAS 5.0 statistical algorithms implemented in the Expressionist software, the intensities of all 11 probe pairs per probe were condensed to one intensity value. For comparability, the microarrays were scaled after condensing to an average signal intensity of 100.
Gene expression analysis was done using the software 'Expression Analyst' (GeneData AG). Gene expression profiles between individual mice were overall compared by principal component analysis using Genesis 1.7.2. (Sturn et al. 2002) . To select testosterone-deregulated genes, we removed probe sets with an expression intensity !20 in each sample. In the next step, only those probe sets were selected, which were deregulated twofold by testosterone on day 0 post infectionem (p.i.) and on day 8 p.i., and these were subjected to two-way ANOVA (P!0 . 01). Genes were analyzed by the Database for Annotation, Visualization, and Integrated Discovery (Dennis et al. 2003) and categorized according to their major biological pathways involved. Genes with similar expression patterns were identified using Gene Cluster 3.0 (Eisen et al. 1998 , de Hoon et al. 2004 ). Data were log 2 -transformed and normalized to the mean expression value for control mice. Hierachical clustering was done using uncentered correlation and average linkage mode.
Quantitative real-time PCR
All RNA samples were treated with DNase of the DNAfree kit (Applied Biosystems, Darmstadt, Germany) for 1 h and then converted into cDNA following the manufacturer's protocol using the QuantiTect Reverse Transcription (RT) kit (Qiagen). Amplifications were performed in the ABI Prism 7500HT Sequence Detection System (Applied Biosystems) using QuantiTect SYBR Green PCR kit (Qiagen) according to the manufacturer's instructions using gene-specific QuantiTect primer assays (Qiagen) for prominin 1 (Prom1), 5 0 -nucleotidase, ecto (Nt5e), sulfotransferase family 2A, dehydroepiandrosteronepreferring, member 2 (Sult2a2), 3 beta-hydroxysteroid dehydrogenase 5 (Hsd3b5), elongation of very long chain fatty acid-like 3 (Elovl3), interferon gamma (Ifng), peroxisome proliferator-activated receptor alpha (Ppara), liver X receptor (Lxr, listed as Nr1h3 in the MGI database), retinoid X receptor alpha (Rxra), pregnane X receptor (Pxr, Nr1i2), farnesoid X receptor (Fxr, Nr1h4), Ar, estrogen receptor alpha (ERa, Esr1), estrogen receptor beta (ERb, Esr2), aryl hydrocarbon receptor (Ahr), hepatic nuclear factor 4 alpha (Hnf4a), constitutive androstane receptor (Car, Nr1i3), and vitamin D receptor (VDR). PCRs were conducted as follows: 2 min at 50 8C to activate uracil-N-glycosylase (UNG), 95 8C for 10 min to deactivate UNG and to activate the PCR, 45 cycles at 94 8C for 15 s, at 60 8C for 30 s, and at 72 8C for 30 s. Reaction specificity was checked by performing dissociation curves after PCR. Relative quantitative evaluation of amplification data was done using Taqman7500 system software v.1.2.3f2 (Applied Biosystems), and the mRNA was normalized to 18S rRNA. The relative expression was measured using the 2 KDDC t method (Livak & Schmittgen 2001) .
Statistical analysis
Student's t-test was used for determination of significant differences (P!0 . 05).
Results

Experimental design
This study is aimed at identifying genes in the female mouse liver, i) the expression of which is persistently deregulated by testosterone and ii) which even remains deregulated during malaria infection. To this end, we followed the experimental outline given in Fig. 1 . Female C57BL/6 mice were treated with testosterone or vehicle twice a week for 3 weeks. The testosteronetreated mice were previously shown to loose their capability of self-healing malaria infections when challenged with 10 6 P. chabaudi-infected erythrocytes (Wunderlich et al. 1988 (Wunderlich et al. , 1991 . The treatment was discontinued for 12 weeks, before the mice were challenged with P. chabaudi malaria reaching peak parasitemia of w50% on day 8 p.i. in both testosteroneand vehicle-pretreated mice. Previously, we have shown that, though the circulating testosterone levels have declined to values characteristic for untreated females, from 3 . 79 to 0 . 21 ng/ml, by the end of the 12-week period of testosterone withdrawal, the mice still succumb to malaria (Benten et al. 1997) . Livers were aseptically removed from three animals at each of the four time points on days 0 and 8 p.i., i.e. at C d0 , C d8 , T d0 , and T d8 as outlined in Fig. 1 . RNA was extracted from individual livers before subjecting to Affymetrix chip analysis. The used MOE430A array contains 22 690 oligo probe sets representing 14 000 different genes. Persistent testosterone effects were identified by twoway ANOVA test evaluating only those genes with at least twofold expression changes at a highly significant P value !0 . 01. Functional annotations of the genes were searched in several databases including SwissProt, Proteome, PubMed, and NetAffx from Affymetrix and Pretreatment of mice for 3 weeks Withdrawal of treatment for 12 weeks
Plasmodium chabaudi for 8 days Figure 1 Experimental outline. Mice were treated with testosterone (T) or vehicle (C) twice a week for 3 weeks. The treatment was then discontinued for 12 weeks, before mice were challenged with 10 6 P. chabaudi-parasitized erythrocytes. Livers were removed from three mice just prior to infection at C d0 and T d0 as well as at peak parasitemia on day 8 p.i. at C d8 and T d8 . were categorized into nine different groups. Quantitative RT-PCR (qRT-PCR) was used to verify expression profiles of several, arbitrarily selected genes from chips.
Overall expression
Principal component analysis revealed that the overall expression profiles were relatively similar among the three different biological replicates per time point, but differed among the four different time points (Fig. 2) . The numbers of testosterone-deregulated genes identified on the microarrays of the four different groups are summarized in a Venn diagram ( Fig. 3) . In toto, the expression of 143 genes was still deregulated by testosterone after 12 weeks of testosterone withdrawal, especially 48 genes were upregulated and 95 genes were downregulated by testosterone (horizontal ellipses in Fig. 3 ). Upon infection with P. chabaudi malaria, 63 genes were deregulated, with 30 genes upregulated and 33 genes downregulated (vertical ellipses in Fig. 3 ). In particular, 24 genes out of the 48 upregulated genes on day 0 p.i. were still upregulated, and 29 genes out of the 95 genes downregulated by testosterone remained suppressed on day 8 p.i. (Fig. 3 ). Only one gene was upregulated by testosterone on day 0 p.i. and became relatively downregulated by malaria on day 8 p.i. (Fig. 3 ).
Gene expression profiles
Out of the 143 genes persistently deregulated by testosterone at the end of the 12-week period of testosterone withdrawal, 54 genes remained significantly deregulated during infection with P. chabaudi malaria on day 8 p.i. (Table 1; cf. overlaps in Venn diagram of Fig. 3 ). The expression profile clustering of these genes is presented in Fig. 4 . Testosterone persistently upregulated the gene expression of well-known male-prevalent enzymes such as CYP2D9, CYP7B1, CYP4A10, UGT2B1, UGT2B38, and HSD3B5 as well as the male-prevalent transporter SLCO1A1 (Table 1) . By contrast, there also remained a persistent downregulation of gene expression of female-prevalent enzymes such as CYP2B9, CYP2B13, CYP3A41, CYP3A44, FMO3, SULT2A2, and SULT3A1 as well as the female-prevalent transporter BC014805. Remarkably, 27 genes, i.e. 50% of the genes, which were deregulated by testosterone, belonged to the categories phase I and phase II metabolism, lipid, and general metabolism. Phase I expression of genes encoding CYP2B13, CYP3A41, and FMO3 and phase II expression of genes encoding SULT2A2 and SULT3A1 were persistently suppressed by testosterone (O100-fold), whereas HSD3B5 showed the highest persistent testosterone-upregulated expression (O100-fold; Table 1 ).
Remarkably, the expression of four genes, which were involved in cancerogenic processes, was persistently deregulated by testosterone. These genes encode LAMA3, NOX4, RAD51L1, and PROM1 (Table 1) . LAMA3 is an indicator of hepatocellular carcinoma dedifferentiation, NOX4 is normally expressed in cancerous tissues, RAD51L1 is involved in genetic instability, and PROM1 is a marker for hematopoietic and endothelial progenitor cells. Furthermore, persistent deregulation also occurred with four genes involved in signal transduction and genes encoding diverse transporters and seven genes of miscellaneous function.
Long-term testosterone-induced deregulation also occurred in expression of genes involved in the immune response, in particular those encoding IFNg and IGK-C (Table 1) . Out of the 24 upregulated genes, 3 genes encoding CYP2D9, ELOVL3, and SUSD4 remained upregulated, but at significantly lower levels after infection on day 8 p.i. By contrast, only the expression of Ifng was increased by testosterone on day 0 p.i. (T d0 /C d0 Z11 . 78), but its upregulation appeared relatively suppressed on day 8 p.i. (T d8 /C d8 Z0 . 58),
i.e. it was strongly induced by infection at C d8 than at T d8 (Table 1) . Finally, Fig. 5 shows that the expression profiles of arbitrarily selected genes from microarrays, i.e. testosterone-upregulated Hsd3b5, Elovl3, and Ifng and testosterone-downregulated Sult2a2, Nt5e, and Prom1, could be verified by real-time PCR analysis.
Nuclear receptors
Nuclear receptors play a central role in liver metabolism of endo-and xenobiotics (Tirona & Kim 2005 , Plant & Aouabdi 2009 ). However, some nuclear receptors such as RXRa, LXRa, and PPARa are not represented on the Affymetrix chip, and others may be removed according to the criteria we applied for analysis. We therefore decided to re-examine a possible persistent testosterone effect on expression of genes encoding some known nuclear receptors using qRT-PCR. Table 2 summarizes data obtained for 12 different receptors. It is conspicuous that after testosterone withdrawal for 12 weeks, only the expression of Car was more than twofold downregulated. However, expression of Car did not remain deregulated by testosterone after infection with P. chabaudi on day 8 p.i.
Discussion
Using Affymetrix microarray technology, the present study has revealed that, among 14 000 genes examined, only 54 genes were persistently deregulated by testosterone in livers of female mice and remained deregulated after subsequent infection with P. chabaudi for 8 days. The fact that only 54 genes out of 14 000 are persistently deregulated by testosterone indicates that this deregulation reflects specific testosterone effects rather than long-term toxic testosterone effects. The genes permanently changed by testosterone can be summarized into three groups: 1) genes involved in liver metabolism, 2) genes involved in hepatocellular carcinogenesis, and 3) genes involved in immune response.
Most of the genes permanently changed by testosterone belong to the first group, i.e. genes encoding enzymes involved in phase I-III liver metabolism. Conspicuously, there is a persistent downregulation of some female-prevalent genes such as Cyp2b9, Cyp2b13, Cyp3a41, Cyp3a44, Fmo3, Sult2a2, Sult3a1, and
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 -5·0 -3·3 -1·7 0 +1·7 +3·3 +5·0 Figure 4 Hierarchical cluster analysis of expression levels of persistently deregulated genes by testosterone, with the upregulated genes on the left and the downregulated genes on the right. Analysis was performed using Gene Cluster 3. All expression levels were normalized to the mean signal intensity of control mice (C d0 ; cf. outline in Fig. 1) , and data are log 2 -transformed. Green and red colors represent down-and upregulation respectively as indicated by the logarithmic color scale bar.
BC014805, and an upregulation of some male-prevalent genes such as Cyp2d9, Cyp7b1, Hsd3b5, Ugt2b1, Ugt2b38, and Slco1a1 (cf. Table 1 ). The testosterone-induced permanent changes of these genes contribute to an at least partial masculinization of the metabolism of the female mouse liver. Such a masculinization is ultimately also in accordance with the testosterone-induced permanent changes of those genes listed in the second group, which are involved in and contribute to hepatocellular carcinogenesis, such as Lama3 and
Nox4. Indeed, hepatocellular carcinoma is known for a long time to be much more prevalent in male mice than in female mice , Nagasue & Kohno 1992 . The changes of Igk-C and Ifng in the third group of testosterone-deregulated genes indicate that testosterone also affects genes involved in the immune response, though our data cannot discriminate as to whether testosterone affects only genes of intrahepatic T-and B-cells and/or also circulatory B-and T-cells. At least, Gene expression profiles of testosteroneupregulated Hsd3b5, Ifng, and Elovl3 on the left and testosteronedownregulated Nt5e, Prom1, and Sult2a2 on the right, as revealed by microarrays, can be verified by real-time PCR analysis. Relative mRNA expression was normalized to the mean expression of control mice (C d0 ). For definition of C d0 , C d8 , T d0 , and T d8 , see outline in Fig. 1 . MeansGS.D. from three different mice are indicated for each group. Significant differences between T d0 and C d0 are indicated by *, and between T d8 and C d8 by § using t-test (P!0 . 05). Table 2 Effects of testosterone pretreatment and Plasmodium chabaudi malaria on gene expression of different nuclear receptors in the female mouse liver as revealed by quantitative reverse transcription-PCR
Gene symbol
Gene name T d0 /C d0 T d8 /C d8 the persistent downregulation of Igk-C by testosterone indicates that testosterone ultimately leads to a partially reduced production of antibodies. Indeed, this confirms previous studies that testosterone lowers the production of antibodies (Fujii et al. 1975 , Hirota et al. 1980 , Morton et al. 1981 , Kincade et al. 1994 , Benten et al. 1997 ). More complicated is the situation with Ifng which is upregulated by the end of the testosterone withdrawal period, but the subsequent malaria infection induces expression of Ifng in both the vehicle-and the testosterone-pretreated mice, however, at a higher extent in control than in testosterone-pretreated mice.
The mechanisms by which testosterone exerts reprograming of gene expression, evidenced as permanent changes in the expression of distinct genes in the female mouse liver, are unknown, but are expected to be rather complex and, possibly, even to be different for different genes, involving both direct and indirect actions of testosterone on gene expression , Centenera et al. 2008 , Bennett et al. 2009 ). An indirect action of testosterone may also take place through the hypothalamus-pituitary gland-liver axis, which is imprinted neonatally by androgens and which operates through pulsatile versus continuous patterns of GH secretion in males versus females respectively (Colby et al. 1973 , Einarson et al. 1973 , Sakuma et al. 2002 , Gustafsson 2005 , Waxman & Holloway 2009 ). Indeed, this axis is currently envisaged as to maintain the sexual dimorphism of hepatic gene expression, especially expression of cytochrome P450 genes involved in liver metabolism. GH in turn activates the GH-responsive transcription factor STAT5b, which is, besides HNF4a, essential for establishment and maintenance of sexually dimorphic gene expression in the liver of male mice (Clodfelter et al. 2007 . In female mice, however, STAT5b plays only -if at all -a minor role in sexually dimorphic pattern of hepatic gene expression . Remarkably, our microarray and qRT-PCR data indicate that testosterone affects expression of neither Stat5b nor Hnf4a in the female mouse liver. Also, any other transcription factors including common nuclear factors are apparently not affected by testosterone. Moreover, testosterone-induced reprograming of liver gene expression may involve changes in the epigenome. Indeed, steroid hormones are known to induce long-lasting chromatin remodeling through epigenetic mechanisms, as e.g. DNA methylation and/or covalent modifications of histones (Grunstein 1997 , Goldberg et al. 2007 , Murray et al. 2009 , Waxman & Holloway 2009 ).
Some of those genes that may be important for the testosterone-induced persistent susceptibility to P. chabaudi malaria have been possibly not detected due to masking since our experiments have been conducted with livers in toto. Also, it is not unlikely that genes may be critical in other organs, as e.g. in the spleen representing the other major effector site against blood stage malaria .
Nevertheless, it appears as if the testosterone-induced permanent changes we have found in hepatic expression of those genes involved in liver metabolism and in particular those involved in immune response are presumably relevant for the testosterone-induced persistent susceptibility to P. chabaudi malaria. For instance, masculinization of liver metabolism possibly reflects a decreased hepatic capacity to detoxify substances, which are derived in abundance from destroyed parasites and host cells during malaria infection. At least, the testosterone-induced decrease in production of antibodies and IFNg indicates an association with the testosterone-induced persistent susceptibility to P. chabaudi malaria. Indeed, the current view predominates that protective immunity to P. chabaudi malaria is eventually mediated through antibodies (Achtman et al. 2005 (Achtman et al. , 2007 requiring activation by the T H 2 response. However, this activation has to be preceded by an IFNg-dependent activation of the T H 1 response (Taylor-Robinson & Phillips 1998 , Balmer et al. 2000 , Su & Stevenson 2000 , Batchelder et al. 2003 , Cernetich et al. 2006 . The specific upregulation of Ifng we observe after testosterone withdrawal could reflect an overactivation of the T H 1 response; the delicately balanced switching to the T H 2 response may be then perturbed (Zhang et al. 2000) , thus delaying the maturation and secretion of the antibodies from plasma B cells. In addition, the testosterone-increased production of IFNg may perturb the proper activation of those genes, which encode, e.g. other effectors directed against infections such as diverse GTPases (Boehm et al. 1998 , Klamp et al. 2003 , Degrandi et al. 2007 ).
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